Form 4: Emergent BioSolutions SVP Withholds Shares for Tax Obligations

William Hartzel, SVP of Bioservices at Emergent BioSolutions Inc., disposed of 4,263 shares of common stock at $7.36 per share to cover tax liabilities associated with restricted stock unit vesting.

Summary

• William Hartzel, the Senior Vice President of Bioservices and an Officer at Emergent BioSolutions Inc. (EBS), reported a transaction on July 11, 2025.
• The transaction involved the disposition of 4,263 shares of common stock.
• These shares were withheld by the issuer at a price of $7.36 per share to satisfy tax obligations arising from the vesting and settlement of restricted stock units.
• Following this transaction, William Hartzel beneficially owns 103,692 shares of Emergent BioSolutions Inc. common stock directly.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary disposition of shares for tax purposes, which is a neutral event and does not indicate positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

This document does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction, specifically a non-discretionary disposition for tax purposes, which is common practice in the biotechnology and pharmaceutical industries when restricted stock units vest. It does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes and does not reflect a change in management's discretionary holdings or confidence in the company.

Key Dates

Keywords

Emergent BioSolutions, EBS, Form 4, Insider Transaction, Stock Disposition, Tax Withholding, Restricted Stock Units, William Hartzel, Bioservices